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OBJECTIVE — Toinvestigatesprint-trainingeffectsonmusclemetabolismduringexercisein
subjects with (type 1 diabetic group) and without (control group) type 1 diabetes.
RESEARCH DESIGN AND METHODS — Eight subjects with type 1 diabetes and
seven control subjects, matched for age, BMI, and maximum oxygen uptake (V ˙ O2peak), under-
took 7 weeks of sprint training. Pretraining, subjects cycled to exhaustion at 130% V ˙ O2peak.
Posttrainingsubjectsperformedanidenticaltest.Vastuslateralisbiopsiesatrestandimmediately
after exercise were assayed for metabolites, high-energy phosphates, and enzymes. Arterialized
venous blood drawn at rest and after exercise was analyzed for lactate and [H
]. Respiratory
measures were obtained on separate days during identical tests and during submaximal tests
before and after training.
RESULTS — Pretraining,maximalrestingactivitiesofhexokinase,citratesynthase,andpyru-
vate dehydrogenase did not differ between groups. Muscle lactate accumulation with exercise
washigherintype1diabeticthannondiabeticsubjectsandcorrespondedtoindexesofglycemia
(A1C, fasting plasma glucose); however, glycogenolytic and glycolytic rates were similar. Post-
training, at rest, hexokinase activity increased in type 1 diabetic subjects; in both groups, citrate
synthase activity increased and pyruvate dehydrogenase activity decreased; during submaximal
exercise, fat oxidation was higher; and during intense exercise, peak ventilation and carbon
dioxideoutput,plasmalactateand[H
],musclelactate,glycogenolyticandglycolyticrates,and
ATP degradation were lower in both groups.
CONCLUSIONS — High-intensity exercise training was well tolerated, reduced metabolic
destabilization (of lactate, H
, glycogenolysis/glycolysis, and ATP) during intense exercise, and
enhancedmuscleoxidativemetabolisminyoungadultswithtype1diabetes.Thelattermayhave
clinically important health beneﬁts.
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epeated bouts of brief, high-
intensity exercise are characterized
not only by marked metabolic and
ionic destabilization in exercising muscle
but also by progressively increasing aero-
bic ATP generation, such that by just the
third 30-s bout, 63% of ATP is generated
oxidatively (1). It is therefore not entirely
surprising that high-intensity (sprint) ex-
ercisetrainingresultsinoxidativeadapta-
tions in muscle. These adaptations
includereducedglycogenolysisandlower
accumulation ofmuscle lactate and hydro-
gen ions during high-intensity matched-
work exercise (2); increased activity of
oxidative enzymes such as citrate synthase
(3–5), cytochrome c oxidase (6), and -
hydroxyacyl-CoA dehydrogenase (-HAD)
(4); reduced ATP degradation during in-
tense exercise (2,5,7); and increased peak
oxygen consumption (V ˙ O2peak) (2–5,8).
Theonlystudy(9)toexaminemuscle
metabolism during exercise in patients
withtype1diabetes(comparedwithcon-
trol subjects) reported lower muscle oxi-
dative capacity and higher glycolytic ﬂux
and acidosis. No studies have directly in-
vestigated the longitudinal effects of exer-
cise training on muscle metabolism in
these patients. Thus, while young adults
with type 1 diabetes undertake exercise
and sports of various intensities, includ-
ing high-intensity exercise and training,
clinicianshavelittleevidenceuponwhich
toprovideadvice.Basedonadaptationsin
healthy subjects, we hypothesized that
high-intensity exercise training in young
adults with type 1 diabetes would in-
crease muscle oxidative capacity, attenu-




METHODS— Eight subjects (ﬁve
men and three women) with type 1 dia-
betes (type 1 diabetic group) ([means 
SD] duration of diabetes 7.1  4.0 years;
A1C 8.6  0.8%) and seven subjects
(four men and three women) without di-
abetes (control group) (A1C 5.3  0.3%)
were recruited concurrently over 3 years.
Control subjects closely matched those
with diabetes for age (type 1 diabetic
group aged 25  4 years; control group
aged 25  4 years), BMI (type 1 diabetic
group 25.4  3.2 kg/m
2; control group
23.8  5.0 kg/m
2), and V ˙ O2peak (type 1
diabeticgroup3.300.97l/min;control
group 3.17  0.79 l/min), as detailed in a
separate report on this study (10). Poten-
tialtype1diabeticsubjectswereexcluded
forproteinuria,microalbuminuria,prolif-
erative retinopathy (10 microaneu-
rysms in the last year), and autonomic or
peripheralneuropathies.Controlsubjects
had no family history of metabolic disor-
ders. No subject smoked or took regular
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were sedentary (i.e., no regular exercise;
type 1 diabetic group, n  1; control
group, n  2) or were recreationally ac-




Testing was conducted after over-
night fasting. Subjects in the type 1 dia-
betic group reduced their evening insulin
dose by 1–2 units to prevent hypoglyce-
mia on the morning of the tests and de-
layed their morning insulin dose until
after testing. All subjects replicated their
pretraining dietary intake (photocopied
record) for the 2 days before posttesting.
Subjects abstained from alcohol con-
sumptionandvigorousexercisefor2days
before each test. Subjects in the type 1
diabetic group recorded daily insulin
dose for 2 weeks before and throughout
training. Seven subjects used a combined
protocolofshort-actingandbasalinsulin,
and one subject used 15/85 neutral/
isophane mixed insulin.
Exercise testing
Incremental test. As previously de-
scribedforthesesubjects(10),asubmaxi-
mal, then incremental (10 W/30 s), cycle
test to fatigue was conducted before (2
days after a familiarization trial) and after
training on an electronically braked er-
gometer (Ergoline 800s; Mijnhardt, the
Netherlands). Steady-state V ˙ O2, V ˙ CO2,
and respiratory exchange ratio were de-
terminedduringtheﬁnalminuteof4-min
workrates of 60, 90, 120, and 150 W.
Three female subjects (TID group, n  2;
control group, n  1) could not complete
150 W before training; thus, an interme-
diate load of 110 W was substituted for
the purpose of generating an individual
regression equation of V ˙ O2 versus power.
Peak V ˙ O2 (V ˙ O2peak) was determined, and
the power output required to elicit 130%
V ˙ O2peak was calculated.
Constantloadsprinttests. Pretraining,
following an identical test on a separate
day (used to collect respiratory data), a
sprint test to exhaustion was conducted
on the cycle ergometer. After a 3-min
warm-up at 20 W, subjects pedaled at a
poweroutputequivalentto130%V ˙ O2peak
until exhaustion. Muscle and blood were
sampled. Posttraining, a test was con-
ducted at the same power output and for
the same duration (i.e., identical work,
with blood and muscle sampling times
matched to pretraining). On a separate
day, respiratory data were collected (time
matched with the pretraining respiratory
test).Expiredvolumewasdeterminedus-
ing a pneumotachometer (Hans Ru-
dolph), and expired gas fractions were
determined by O2 and CO2 analyzers
(Ametek; Thermox Instruments, Pitts-
burgh, PA), which were calibrated imme-
diately before and after each test.
Muscle sampling and analyses
Percutaneous muscle biopsies with suc-
tion were performed at rest and immedi-
ately after exercise (on the cycle
ergometer). Muscle samples (type 1 dia-
betic group, n  7; control group, n  6)
were immediately immersed in liquid ni-
trogenthendividedandstoredat80°C.
For enzymes, frozen wet muscle (30
mg) was homogenized in a medium com-
prising 50 mmol/l Tris-HCl, 20 mmol/l
EGTA, 25 mmol/l NaF, and 1 mmol/l
benzamidine, pH 7.4. Activities of hexo-
kinase (11), the activated form of pyru-
vate dehydrogenase (PDHa), and citrate
synthase (12) were determined spectro-
photometrically (Cary3; Varian, Mul-
grave, Victoria, Australia) at 30°C in the
assay media for each enzyme and ex-
pressed relative to the respective pre- or
posttraining peak total creatine (TCr)
content as millimoles per minute per ki-
logramofdrymass.Formetabolites,mus-
cle was weighed, freeze dried, reweighed,
dissected free of connective tissue and
blood, powdered, and extracted. Extracts
wereanalyzedforATP,PCr,creatine,glu-
cose, glycogen, glycolytic intermediates,
and lactate on a luminescence spectrom-
eter (Aminco Bowman Series 2; SLM In-
struments, Urbana, IL) as previously
described (2). Metabolites (except glyco-
gen, glucose, pyruvate, and lactate) in
pre- and posttraining samples were ex-
pressed relative to the peak TCr obtained
before and after training, respectively, as
millimoles per kilogram of dry mass. The




seconds and expressed as millimoles per
kilogram of dry mass per second, where
G1-Pisglucose1-phosphate,G6-Pisglu-
cose 6-phosphate, F6-P is fructose
6-phosphate, Lac is lactate, and Pyr is
pyruvate.
Blood sampling and analyses
Arterialized blood was sampled from a
dorsal hand vein at rest in the ﬁnal sec-
onds of exercise and during an hour of
recovery. As previously described for this
study, A1C (13), catecholamines, blood
gases, hemoglobin, hematocrit, plasma
sodium, potassium, and glucose, gluca-
gon, and insulin levels were determined
(10). pH was determined in duplicate im-
mediately by blood gas analysis (Corning
865; Chiron Diagnostics) and plasma
[H
] calculated. The remaining blood
was centrifuged, and 250 	l of plasma
wasmixedwith500	l0.6mol/lperchlo-
ric acid, centrifuged, the supernatant re-
moved, and stored at 20°C until
analysis.Plasmalactateconcentrationwas
determined in triplicate as previously de-
scribed (2).
Exercise training
Subjects undertook 7 weeks of super-
vised, progressive high-intensity cycling
training, thrice weekly, as previously de-
scribed(2,8,10,13).Eachtrainingsession
comprised 4–10 30-s “all out” sprints on
an ergometer (Monark 668; Varberg,
Sweden), with each sprint separated by a
3- to 4-min passive rest. The number of
sprint bouts per session was increased
from four in week 1 to six in week 2,
eight in week 3, and 10 in weeks 4–7; the
rest interval was reduced from 4 to 3 min
in weeks 5–7 of training.
Statistics
Data were analyzed using t tests for base-
line variables and insulin dosage data and
repeated-measures ANOVA for muscle,
blood, and respiratory measures (within-
subject factors: training status  sample
time;between-subjectfactor:group;SPSS
10.0 for Windows). The Wilks’ 
 multi-
variate adjustment was used for blood
data. Signiﬁcant F ratios for blood data
were further examined using a post hoc




Power output in the constant-load tests
did not differ between groups (type 1 di-
abeticgroup,34041W;controlgroup,
350  39 W; P  0.86). Pretraining, in
both groups, time to fatigue did not differ
between the respiratory (65  4s )a n d
blood and muscle (70  5s ;P  0.14)
tests.
Daily insulin dosage
The daily insulin dose in the type 1 dia-
betic group (52.4  3.8 units/day) was
not altered by training (51.2  4.6 units/
day; P  0.66).
High-intensity exercise and type 1 diabetes
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During submaximal exercise posttrain-
ing, the respiratory exchange ratio was
lower (P  0.05), with no group differ-
ences(P0.95)(60W:pretraining,type
1 diabetic group 0.88  0.02 and control
group 0.90  0.03; posttraining, type 1
diabetic group 0.86  0.02 and control
group 0.86  0.03; 90 W: pretraining,
type 1 diabetic group 0.97  0.02 and
control group 0.94  0.03; posttraining,
type 1 diabetic group 0.92  0.02 and
control group 0.91  0.02; and 120 W:
pretraining, type 1 diabetic group 1.01 
0.04 and control group 0.98  0.03;
posttraining, type 1 diabetic group
0.98  0.03 and control group 0.94 
0.03).
Ventilation and plasma acidosis
Peak V ˙ O2 did not differ between the con-
stant-load (3.29  0.21 l/min) and incre-
mental tests (3.24  0.22 l/min; P 
0.56). Pretraining in the constant-load
test, the groups did not differ on any re-
spiratory variable (Table 1). Posttraining,
during identical exercise, estimated to
elicit 125  0.03% of pretraining V ˙ O2peak
(P  0.06), peak expired ventilation and
carbon dioxide output were reduced,
with no group differences. Plasma lactate
and [H
] were less elevated posttraining,
withnogroupdifferences(Fig.1AandB).
Muscle metabolism
Peak TCr did not differ with training
(117.6  3.5 vs. 119.5  3.4 mmol/kg
dm, pre- vs. posttraining, respectively;
P  0.35) or between groups (P  0.63).
Muscle free glucose content rose with ex-
ercise (Table 2), was unaffected by train-
ing, and was higher in the type 1 diabetic
group. Glycogen content was reduced
37  3% by exercise pretraining (Table
2), with no group differences. Posttrain-
ing, glycogen degradation tended to be
less (P  0.07). Glycolytic intermediate
(glucose 1-phosphate, glucose 6-phos-
phate, and fructose 6-phosphate) content
increased with exercise (Table 2), with no
difference after training or between
groups. Muscle pyruvate content in-
creased approximately sixfold with in-
tense exercise and was nearly halved after
training (Table 2), with a tendency for a
greater effect in the type 1 diabetic group
(P0.06).Musclelactateduringexercise
was higher in the type 1 diabetic group
pretraining (Table 2), and lactate accu-
mulation was strongly correlated with in-
dexes of glycemia (A1C and fasting
plasma glucose; both r
2  0.45, P 
0.01). Posttraining, lactate during exer-
cise was reduced, more so in the type 1
diabeticgroup,andtherewasnorelation-
ship between lactate accumulation and
A1C (r
2  0.02, P  0.96) or fasting
plasma glucose (r
2  0.16, P  0.60).
Estimated rates of glycogenolysis and gly-
colysis during exercise pretraining did
not differ between groups and were
20% lower posttraining (Fig. 1C). Mus-
cle ATP content was reduced with exer-
cise before training (P  0.001; type 1
diabetic group, rest 22.8  1.0 mmol/kg
dm, exercise 16.1  0.6 mmol/kg dm;
control group, rest 22.9  0.8 mmol/kg
dm, exercise 17.5  0.5 mmol/kg dm).
Posttraining, ATP degradation during ex-
ercise was attenuated (P  0.01; type 1
diabetic group, rest 21.3  0.5 mmol/kg
dm, exercise 19.5  1.0 mmol/kg dm;
control group, rest 20.6  0.7 mmol/kg
dm, exercise 17.5  1.0 mmol/kg dm)
more so in the type 1 diabetic group (P 
0.05).
Muscle enzyme activity
Pretraining, resting activities of hexoki-
nase,PDHa(Table2),andcitratesynthase
(Fig. 1D) did not differ between groups
nor did the hexokinase–to–citrate syn-
thase ratio. Posttraining, hexokinase ac-
tivity increased in the type 1 diabetic
group only, whereas citrate synthase ac-
tivity increased in both groups. Conse-
quently, the hexokinase–to–citrate
synthase ratio was increased in the type 1
diabetic group and reduced in the control
group (P  0.01; data not shown). For
both hexokinase and citrate synthase, en-
zyme activity was reduced with exercise
inthecontrolgroupbutunchangedinthe
type1diabeticgroup.Posttraining,PDHa
activity at rest was reduced; however,
there was no difference in PDHa immedi-
ately after exercise, and there were no
group differences.
CONCLUSIONS — The key ﬁndings
in this study were that high-intensity ex-
ercise training increased activity of citrate
synthase and reduced activity of PDHa at
rest; increased fat oxidation during sub-
maximal exercise; and during intense ex-
ercise, reduced ventilation and carbon
dioxideoutput,loweredplasmaandmus-
cle lactate accumulation, and lowered the
glycogenolytic and glycolytic rates, and
attenuated ATP degradation in young
adults with type 1 diabetes. Together,
these ﬁndings demonstrate that high-
intensitytrainingincreasedmuscleoxida-
tive capacity and reduced myocellular
metabolic destabilization and glycolytic
rate during intense exercise in type 1
diabetes.
Before training, muscle lactate accu-
mulationwashigherinthetype1diabetes
than the control group and was positively
correlated with indexes of glycemia. The
data may suggest lower muscle lactate
transportand/orPDHaactivityinthetype
1 diabetic group. However, PDHa did not
differ between groups. The only previous
study to examine muscle PDHa in pa-
Table 1—Respiratory data during the pre- and posttraining respiratory tests conducted at
130% pretraining V ˙ O2peak
Variable Pretraining Posttraining
V ˙ Epeak (l/min)*
Type 1 diabetic group 96.1  10.3 79.5  7.0
Control group 104.6  10.4 94.3  8.1
V ˙ O2peak (l/min)*
Type 1 diabetic group 3.44  0.33 3.14  0.27
Control group 3.12  0.28 3.03  0.35
Mean V ˙ O2 (l/min)
Type 1 diabetic group 2.49  0.21 2.33  0.18
Control group 2.32  0.23 2.35  0.23
V ˙ CO2peak
(l/min)†
Type 1 diabetic group 3.52  0.42 3.01  0.30
Control group 3.47  0.42 3.20  0.38
V ˙ E/V ˙ CO2
Type 1 diabetic group 28.0  1.1 26.9  1.3
Control group 30.7  1.6 30.4  1.8
Data are means  SE. Type 1 diabetic group, n  8; control group, n  7. V ˙ Epeak, peak expired ventilation,
BTPS; V ˙ O2peak, peak oxygen uptake, STPD; V ˙ CO2peak, peak carbon dioxide output, STPD; VE/V ˙ CO2, peak
ventilatory equivalent for carbon dioxide. *P  0.05; †P  0.01 pretraining vs. posttraining.
Harmer and Associates
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no difference at rest compared with con-
trol subjects (14). Thus, although specu-
lative, it is possible that our type 1
diabetic group had lower muscle lactate
transportduringintenseexercisethanthe
control group. While no study has exam-
ined muscle lactate transport in type 1
diabetes, the muscle lactate transporter
content was reduced, and muscle lactate
higher, in patients with type 2 diabetic
compared with control subjects (15). The
strong association between muscle lactate
accumulation and glycemic indexes be-
fore training in the present study may re-
ﬂect a degree of lactate-induced insulin
resistance (16), or it is possible that mild
insulin deﬁciency or hyperglycemia may
affect lactate transport; however, this re-
mains to be tested.
The similar glycolytic rate during ex-




However, our data contrast with the
higher glycolytic rate (and lower oxida-
tive capacity) demonstrated with
31P–
magnetic resonance spectroscopy in the
only other study to investigate muscle
metabolism during exercise in patients
with type 1 diabetes versus control sub-
jects (9). The divergent ﬁndings in the
two studies may be due to differing nutri-
tional and insulin status and/or to within-
study differences in aerobic ﬁtness. In
contrast to the present study, Crowther et
al.’s (9) subjects had eaten and adminis-
tered insulin before exercise and were not
matched for V ˙ CO2peak with control sub-
jects. Further, the divergence may be
partly explained by the differing nature of
muscle contraction utilized (high-
frequencydynamicversusisometricexer-
cise, in which blood ﬂow is effectively
occluded).
After training, hexokinase activity in-
creased, and while citrate synthase activ-
ity also increased, the hexokinase–to–
citrate synthase ratio was increased in the
type 1 diabetic group. Theoretically, this
couldfavorglycolysisoveroxidationdur-
ing exercise after training; however, this
was not evident and there was actually a
20% reduction in the glycolytic rate (in
both groups), consistent with more ATP
beinggeneratedoxidatively.Anincreased
hexokinase–to–citrate synthase ratio is
suggested to be an expression of insulin
resistance in type 2 diabetes (18). In type
Figure1—AlldataaremeansSE.AandB:Plasmalactateandhydrogenionconcentrationsatrest,intheﬁnalsecondsofexercise(u),andduring
1 h of recovery in the group with type 1 diabetes (triangles) and the nondiabetic control group (circles), before (white symbols) and after (black
symbols) training. A: Plasma lactate concentration: a, main effects of time, P  0.001; b, training status, P  0.05; c, training status-by-time
interaction, P  0.05, pre-  posttraining. *P  0.05; **P  0.01; ***P  0.001. There were no signiﬁcant interaction effects for group: training
status-by-group, P  0.27; time-by-group, P  0.50; or training status-by-time-by-group, P  0.75. B: Hydrogen ion concentration: a, main effects
of time, P  0.001; b, training status, P  0.001; c, training status-by-time interaction, P  0.05, pre-  posttraining. **P  0.01; ***P  0.001.
There were no signiﬁcant interaction effects for training status-by-group, P  0.28; time-by-group, P  0.44; or training status-by-time-by-group,
P  0.32. ‚, type 1 diabetes pretraining; Œ, type 1 diabetes posttraining; E, control pretraining; F, control posttraining. C: Estimated rates of
glycogenolysis (total histogram) and glycolysis (hatched bar): both, d, main effect of training status, P  0.01, pre-  posttraining. D: Citrate
synthase activity (maximal in vitro). R, rest; Ex, end-exercise. d, main effect of training status, P  0.01, post-  pretraining; e, time-by-group
interaction, P  0.05, type 1 diabetes unchanged, control reduced with exercise. T1D, type 1 diabetic group; CON, control group.
High-intensity exercise and type 1 diabetes
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mon and insulin action is inversely re-
lated to A1C (19). A1C was unchanged
after training in the present study (pre-
training 8.6%, posttraining 8.1%, P 
0.09) (13); however, we did not measure
insulin sensitivity. Future studies investi-
gatingeffectsofhigh-intensitytrainingon
insulin sensitivity would be of interest.
During submaximal exercise after
training, muscle fat oxidation was greater
and carbohydrate oxidation less (as esti-
mated by the respiratory exchange ratio).
This typical “glycogen-sparing” effect of
endurance training has recently been
demonstrated after sprint training (4),
and our study extends this ﬁnding to in-
clude those with diabetes. Interestingly,
higher basal and insulin-stimulated fat
oxidation in patients with type 1 diabetes
compared with control subjects is associ-
ated with insulin resistance and manifests
metabolic inﬂexibility (20). However,
discussing a similar paradox, Kelley and
Mandarino (21) suggest that muscle lipid
handling should be interpreted relative to
oxidative enzyme capacity. The type 1 di-
abetes and control groups adapted simi-
larly to training, i.e., higher fat oxidation
during submaximal exercise and also
higher oxidative enzyme capacity. Addi-
tionally, there was no difference in glyco-
genolysisduringintenseexercisebetween
thegroups,whichsuggeststhatthetype1
diabetic group was as “metabolically ﬂex-
ible” (i.e., able to switch to greater carbo-
hydrate oxidation) (21) as the control
group.
During intense exercise after train-
ing, reduced metabolic destabilization
was evident (i.e., less increase in venti-
lation, V ˙ O2, plasma lactate and [H
],
muscle pyruvate and lactate, and less
ATP degradation; the glycogenolytic
and glycolytic rates were lower; and ci-
trate synthase activity increased in both
groups).Theseadaptationsreﬂectanin-
crease in leg muscle oxidative metabo-
lism after training. This is supported by
the increased V ˙ O2peak during incremen-
tal exercise after training in these sub-
jects (10). The results from the present
study are consistent with our previous
ﬁndings with sprint training in healthy
men (2).
In the present study, PDHa was re-
ducedatrestafterexercisetraining.PDHa
regulates pyruvate entry into the mito-
chondrion, thus being a key determinant
oftheamountoflactateaccumulationand
oxidative pyruvate metabolism. In ro-
dents, PDHa is inhibited by pyruvate de-
hydrogenase kinase, which is increased
by greater fat oxidation (22). Endurance-
trainedratshadlowermusclePDHacom-
pared with sedentary controls, likely due
to their higher activities of -hydroxya-
cyl-CoA dehydrogenase (a -oxidation
enzyme) and pyruvate dehydrogenase ki-
nase(23).Thisexplanationforlowerrest-
ing PDHa is plausible in the present
study, as it has been shown that sprint
training increases -hydroxyacyl-CoA
dehydrogenase (4). Since signiﬁcant fat
oxidation may occur during brief intense
exercise (24), it is possible that a higher
proportion of ATP was derived oxida-
tively from intramuscular fat after train-
ing. Also, although PDHa during exercise
did not differ after training, the lower rate
of glycogenolysis would likely permit a
higher proportion of pyruvate to be oxi-
dized, as we previously speculated (2),
which is consistent with lower lactate ac-
cumulation and attenuated ATP degrada-
tion after training.
In summary, the major difference
before training was higher muscle lac-
tate accumulation during intense exer-
cise in the type 1 diabetic group. Since
glycolytic rates and PDHa activity were
similar between the groups, this may
have been due to lower muscle lactate
transport. The key metabolic adapta-
tions to high-intensity exercise training
in both groups show that the glycolytic
rate and metabolic destabilization were
reduced and citrate synthase activity in-
creased. These adaptations strongly
suggest that muscle oxidative metabo-
lism was increased during intense exer-
cise after high-intensity training in
young adults with type 1 diabetes. Im-
portantly, high-intensity training was
Table 2—Muscle metabolites and enzyme activity
Type 1 diabetic group Control group
Rest Exercise Rest Exercise
Glycogen (glucosyl units)*
Pretraining 491  50 306  37 526  53 347  60
Posttraining 499  61 366  63 537  49 399  39
Glucose 1-phosphate*
Pretraining 0.1  0.0 0.8  0.2 0.1  0.0 0.9  0.2
Posttraining 0.1  0.0 0.8  0.2 0.1  0.0 0.6  0.1
Glucose*†
Pretraining 3.8  0.7 4.9  0.6 1.8  0.4 3.5  0.6
Posttraining 2.9  0.3 6.2  1.1 1.3  0.1 3.2  0.3
Glucose 6-phosphate*
Pretraining 1.5  0.3 23.3  1.8 1.4  0.22 22.2  2.7
Posttraining 1.5  0.2 20.1  2.2 1.2  0.2 19.4  1.8
Fructose 6-phosphate*
Pretraining 0.2  0.0 3.5  0.2 0.2  0.0 3.2  0.4
Posttraining 0.2  0.0 3.1  0.3 0.2  0.0 3.2  0.4
Pyruvate*‡§
Pretraining 0.2  0.0 0.9  0.2 0.1  0.0 0.6  0.0
Posttraining 0.1  0.0 0.4  0.1 0.2  0.0 0.6  0.1
Lactate*¶#**
Pretraining 3.4  0.3 114.8  4.3 4.2  0.7 88.6  7.0
Posttraining 4.0  0.6 80.0  7.2 3.9  0.5 78.3  4.7
Hexokinase††‡‡
Pretraining 8.9  0.5 8.5  0.4 9.0  0.6 6.6  0.6
Posttraining 12.9  0.7 12.3  0.4 9.5  0.6 7.3  0.6
Pyruvate dehydrogenase a*§§
Pretraining 0.8  0.1 1.9  0.3 1.0  0.2 2.1  0.3
Posttraining 0.6  0.1 1.7  0.2 0.5  0.1 1.7  0.2
Data are means  SE. Type 1 diabetic group, n  7; Control group, n  6. Units for muscle metabolites,
mmol/kg dm; units for enzyme activity, mmol   min
1   kg dm
1.* P  0.001, main effect of time, exercise
 rest (except for glycogen, which is rest  exercise); †P  0.01, Type 1 diabetic  Control group; ‡P 
0.05, main effect of training status; §P  0.05, training status-by-time interaction; P  0.01, main effect of
training status; ¶P  0.001, training status-by-time interaction; #P  0.05, time-by-group interaction;
**P  0.05, training status-by-time-by-group interaction; ††P  0.001, time-by-group interaction: T1D
group unchanged, CON group reduced with exercise; ‡‡P  0.01, training status-by-group interaction:
Type 1 diabetic  Control; §§P  0.05, training status at rest, pre-  posttraining.
Harmer and Associates
DIABETES CARE, VOLUME 31, NUMBER 11, NOVEMBER 2008 2101well-tolerated and did not have any ev-
ident adverse effects in our patients,
even though they were in moderate to
poor metabolic control. Increased skel-
etal muscle oxidative capacity is a desir-
able health outcome, particularly for
those with diabetes. The oxidative ad-
aptations to high-intensity exercise
training may confer clinically important
health beneﬁts in young patients with
type 1 diabetes; however, this remains
to be established.
Acknowledgments— We were fortunate to
havehadtheassistanceofthelateJanetBryson
(Department of Nutrition and Biochemistry,
The University of Sydney), who skillfully per-
formed the enzyme assays. We acknowledge
theinspirationofouresteemedfriendandcol-
league, Professor John R. Sutton, who passed
away in 1996. We are very appreciative of the
dedication of our subjects during strenuous
testingandexercisetraining.Weacknowledge
the excellent assistance of Associate Professor
Martin Thompson and Dr. Greg Bennett with
venepuncture, Drs. Grace Bryant and James
Harrison with muscle biopsies, and Dr. Rob
Heardwithstatisticsadvice.Wearegratefulto
Drs. Andrew Krzyszton and Rob Coles for as-
sistance with patient recruitment.
References
1. Putman CT, Jones NL, Lands LC, Bragg
TM, Hollidge-Horvat MG, Heigenhauser
GJF:Skeletalmusclepyruvatedehydroge-
nase activity during maximal exercise in
humans. Am J Physiol Endocrinol Metab
269:E458–E468, 1995
2. Harmer AR, McKenna MJ, Sutton JR,
Snow RJ, Ruell PA, Booth J, Thompson
MW, Mackay NA, Stathis CG, Crameri
RM,CareyMF,EagerDM:Skeletalmuscle
metabolic and ionic adaptations during
intense exercise following sprint training
in humans. J Appl Physiol 89:1793–1803,
2000
3. MacDougallJD,HicksAL,MacDonaldJR,
McKelvie RS, Green HJ, Smith KM: Mus-
cle performance and enzymatic adapta-
tions to sprint interval training. J Appl
Physiol 84:2138–2142, 1998
4. Burgomaster KA, Howarth KR, Phillips
SM, Rakobowchuk M, MacDonald MJ,
McGee SL, Gibala MJ: Similar metabolic
adaptations during exercise after low vol-
umesprintintervalandtraditionalendur-
ance training in humans. J Physiol 586:
151–160, 2008
5. Barnett C, Carey M, Proietto J, Cerin E,
Febbraio MA, Jenkins D: Muscle metabo-
lism during sprint exercise in man: inﬂu-
ence of sprint training. J Sci Med Sport
7:314–322, 2004
6. Gibala MJ, Little JP, van Essen M, Wilkin
GP, Burgomaster KA, Safdar A, Raha S,
Tarnopolsky MA: Short-term sprint inter-
val versus traditional endurance training:
similar adaptations in human skeletal
muscle and exercise performance. J Physiol
575:901–911, 2006
7. Stathis CG, Febbraio MA, Carey MF, Snow
RJ: Inﬂuence of sprint training on human
skeletal muscle purine nucleotide metabo-
lism. J Appl Physiol 76:1802–1809, 1994
8. McKenna MJ, Heigenhauser GJF, Mc-
Kelvie RS, Obminski G, MacDougall JD,
Jones NL: Enhanced pulmonary and ac-
tive skeletal muscle gas exchange during
intense exercise after sprint training in
men. J Physiol 501:703–716, 1997
9. Crowther GJ, Milstein JM, Jubrais SA,
Kushmerick MJ, Gronka RK, Conley KE:
Altered energetic properties in skeletal
muscle of men with well-controlled insu-
lin-dependent (type 1) diabetes. Am J
Physiol 284:E655–E662, 2003
10. Harmer AR, Ruell PA, McKenna MJ, Ch-
isholm DJ, Hunter SK, Thom JM, Morris
NR, Flack JR: Effects of sprint training on
extrarenal potassium regulation with in-
tense exercise in type 1 diabetes. J Appl
Physiol 100:26–34, 2006
11. Gauthier JM, Theriault R, Theriault G,
Gelinas Y, Simoneau J-A: Electrical stim-
ulation-induced changes in skeletal mus-
cle enzymes of men and women. Med Sci
Sports Exerc 24:1252–1256, 1992
12. Coore HJ, Denton RM, Martin BR, Randle
PJ: Regulation of adipose tissue pyruvate
dehydrogenase complex by insulin and
other hormones. Biochem J 125:115–127,
1971
13. Harmer AR, Chisholm DJ, McKenna MJ,
Morris NR, Thom JM, Bennett G, Flack
JR: High-intensity training improves
plasma glucose and acid-base regulation
during intermittent maximal exercise in
type 1 diabetes. Diabetes Care 30:1269–
1271, 2007
14. Kruszynska YT, Petranyi G, Home PD,
Taylor R, Alberti KGMM: Muscle enzyme
activity and insulin sensitivity in type 1
(insulin-dependent) diabetes mellitus.
Diabetologia 29:699–705, 1986
15. Juel C, Holten MK, Dela F: Effects of
strengthtrainingonmusclelactaterelease
and MCT1 and MCT4 content in healthy
andtype2diabetichumans.JPhysiol556:
297–304, 2004
16. Choi CS, Kim Y-B, Lee FN, Zabolotny JM,
Kahn BB, Youn JH: Lactate induces insu-
lin resistance in skeletal muscle by sup-
pressing glycolysis and impairing insulin
signaling. Am J Physiol Endocrinol Metab
283:E233–E240, 2002
17. Berger M, Hagg SA, Goodman MN, Ruder-
man NB: Glucose metabolism in perfused
skeletal muscle: effects of starvation, diabe-
tes, fatty acids, acetoacetate, insulin and ex-
ercise on glucose uptake and disposition.
Biochem J 158:191–202, 1976
18. Simoneau J-A, Kelley DE: Altered glyco-
lytic and oxidative capacities of skeletal
muscle contribute to insulin resistance in
NIDDM.JApplPhysiol83:166–171,1997
19. Yki-Ja ¨rvinen H, Koivisto VA: Natural
course of insulin resistance in type 1 dia-
betes. N Engl J Med 315:224–230, 1986
20. WohlP,WohlP,GirmanP,Pelika ´nova ´T :
Inﬂexibility of energy substrate oxidation
in type 1 diabetic patients. Metabolism 53:
655–659, 2004
21. Kelley DE, Mandarino LJ: Fuel selection
in human skeletal muscle in insulin resis-
tance: a reexamination. Diabetes 49:677–
683, 2000
22. Holness MJ, Kraus A, Harris RA, Sugden
MC: Targeted upregulation of pyruvate
dehydrogenase kinase (PDK)-4 in slow-
twitchskeletalmuscleunderliesthestable
modiﬁcation of the regulatory character-
istics of PDK induced by high-fat feeding.
Diabetes 49:775–781, 2000
23. Nakai N, Sato Y, Oshida Y, Fujitsuka N,
Yoshimura A, Shimomura Y: Insulin acti-
vation of pyruvate dehydrogenase com-
plex is enhanced by exercise training.
Metabolism 48:865–869, 1999
24. McCartney N, Spriet LL, Heigenhauser
GJF, Kowalchuk JM, Sutton JR, Jones NL:
Muscle power and metabolism in maxi-
mal intermittent exercise. J Appl Physiol
60:1164–1169, 1986
High-intensity exercise and type 1 diabetes
2102 DIABETES CARE, VOLUME 31, NUMBER 11, NOVEMBER 2008